These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


429 related items for PubMed ID: 11350682

  • 1. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
    Ding H, Chen Y, Feng X, Liu D, Wu A, Zhang L.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
    [Abstract] [Full Text] [Related]

  • 2. [Diagnostic value of five serum markers for liver fibrosis].
    Luo R, Yang S, Xie J, Zhao Z, He Y, Yao J.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
    [Abstract] [Full Text] [Related]

  • 3. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
    Chen YP, Feng XR, Dai L, Ding HB, Zhang L.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
    [Abstract] [Full Text] [Related]

  • 4. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
    Zheng M, Cai W, Weng H, Liu R.
    Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034
    [Abstract] [Full Text] [Related]

  • 5. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH, Park CK, Kim ES, Park SY, Jo CM, Tak WY, Kweon YO, Kim SK, Choi YW.
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [Abstract] [Full Text] [Related]

  • 6. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
    Ueno T, Inuzuka S, Sata M, Koh H, Tamaki S, Kin M, Sugawara H, Sakata R, Torimura T, Tanikawa K.
    Hepatogastroenterology; 1995 Jun; 42(5):522-7. PubMed ID: 8751209
    [Abstract] [Full Text] [Related]

  • 7. [Serum markers and pathological evaluation in hepatitis fibrosis of chronic hepatitis B treated with interferon alpha].
    Deng L, Zhou Y, Peng X, Deng H, Deng Y, Yao J.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():66-7. PubMed ID: 11509145
    [Abstract] [Full Text] [Related]

  • 8. [Clinical and pathological study on liver fibrosis in viral hepatitis].
    Xin S, Mao Y, Wang L, Li Y, Li L, Yu H, Zhao M, Zhang S, Wang S, Wang X, Chen L, Zhou X, Zhou Y, Zou Z, Tang S, Huangpu Y, Zhang L.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):240-3. PubMed ID: 15617338
    [Abstract] [Full Text] [Related]

  • 9. The relationship between staging of hepatic fibrosis and the levels of serum biochemistry.
    Xu GG, Luo CY, Wu SM, Wang CL.
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):246-8. PubMed ID: 14612277
    [Abstract] [Full Text] [Related]

  • 10. [Serum type IV collagen and laminin in patients with chronic hepatitis and its clinical significance].
    Xie J, OuYang K, Su T.
    Hunan Yi Ke Da Xue Xue Bao; 1998 May; 23(1):93-6. PubMed ID: 10681810
    [Abstract] [Full Text] [Related]

  • 11. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS, Wang BE, Wang TL, Jia JD, Qian LX.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of the ELISA and the enhanced chemiluminescence immunoassay in use to determine the serum markers for liver fibrosis].
    Guo JX, Ma HB, Li YL, Xu J, Yang LH, Shi JB, Li B, Liu AX, Li XX, Li BA, Mao YL.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):71-3. PubMed ID: 19799025
    [Abstract] [Full Text] [Related]

  • 13. [Value of simultaneous determination of serum hyaluronic acid, collagen type IV and the laminin level in diagnosing liver fibrosis].
    Liang XH, Zheng H.
    Hunan Yi Ke Da Xue Xue Bao; 2002 Feb 28; 27(1):67-8. PubMed ID: 12575242
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
    Grimbert S, Trinchet JC, Hartmann DJ, Munz C, Garnier M, Mal F, Callard P, Beaugrand M.
    Gastroenterol Clin Biol; 1993 Feb 28; 17(8-9):570-7. PubMed ID: 8253314
    [Abstract] [Full Text] [Related]

  • 15. Non-invasive diagnostic screening of hepatic fibrosis in patients with chronic hepatitis B.
    Chen YP, Feng XR, Dai L, Zhang L, Hou JL.
    Chin Med J (Engl); 2004 Jul 28; 117(7):1109-12. PubMed ID: 15265393
    [No Abstract] [Full Text] [Related]

  • 16. [Serum fibrosis markers in diagnosing liver fibrosis].
    Liu J, Wang JY, Lu Y.
    Zhonghua Nei Ke Za Zhi; 2006 Jun 28; 45(6):475-7. PubMed ID: 16831325
    [Abstract] [Full Text] [Related]

  • 17. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
    Ding XJ, Li SB, Li SZ, Liu HS, Liu B, Xu FM, Gu RW.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec 28; 13(12):911-4. PubMed ID: 16381637
    [Abstract] [Full Text] [Related]

  • 18. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis.
    Xie SB, Yao JL, Zheng RQ, Peng XM, Gao ZL.
    Hepatobiliary Pancreat Dis Int; 2003 Feb 28; 2(1):69-72. PubMed ID: 14607650
    [Abstract] [Full Text] [Related]

  • 19. Assessment of liver fibrosis development in chronic hepatitis B patients by serum hyaluronic acid and laminin levels.
    Parsian H, Rahimipour A, Nouri M, Somi MH, Qujeq D.
    Acta Clin Croat; 2010 Sep 28; 49(3):257-65. PubMed ID: 21462814
    [Abstract] [Full Text] [Related]

  • 20. [Relationship between serum HBV DNA levels and hepatic fibrosis markers in chronic hepatitis B].
    Dong Z, Shen H, Zhang FK.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun 28; 21(2):129-31. PubMed ID: 17653313
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.